^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Clostridium novyi-NT
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
BioMed Valley Discoveries
Drug class:
Cell death stimulant
Related drugs:
Phase 1
M.D. Anderson Cancer Center
Active, not recruiting
Last update posted :
10/31/2024
Initiation :
07/10/2018
Primary completion :
10/01/2026
Completion :
10/01/2026
PD-L1
|
Keytruda (pembrolizumab) • Clostridium novyi-NT
Share
